These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5206 related articles for article (PubMed ID: 6198103)

  • 1. Target level blocking of T-cell cytotoxicity for human malignant melanoma by monoclonal antibodies.
    Knuth A; Dippold W; Meyer zum Bueschenfelde KH
    Cell Immunol; 1984 Feb; 83(2):398-403. PubMed ID: 6198103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
    Bernhard H; Karbach J; Wölfel T; Busch P; Störkel S; Stöckle M; Wölfel C; Seliger B; Huber C; Meyer zum Büschenfelde KH
    Int J Cancer; 1994 Dec; 59(6):837-42. PubMed ID: 7989126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of autoreactive cytolytic T lymphocyte clone against human melanoma by anti-T3 monoclonal antibody and autologous accessory cells.
    Tatake RJ; Guha A; Mukherji B
    Cell Immunol; 1987 Aug; 108(1):42-52. PubMed ID: 3111724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target cells.
    Lakhdar M; Senik A; Fridman WH
    Cell Immunol; 1984 Feb; 83(2):414-21. PubMed ID: 6198104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells.
    Welt S; Carswell EA; Vogel CW; Oettgen HF; Old LJ
    Clin Immunol Immunopathol; 1987 Nov; 45(2):214-29. PubMed ID: 3665201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct cytotoxic T lymphocyte subpopulations in patients with Vogt-Koyanagi-Harada disease that recognize human melanoma cells.
    Maezawa N; Yano A
    Microbiol Immunol; 1984; 28(2):219-31. PubMed ID: 6203018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells.
    Somasundaram R; Robbins P; Moonka D; Loh E; Marincola F; Patel A; Guerry D; Herlyn D
    Int J Cancer; 2000 Jan; 85(2):253-9. PubMed ID: 10629086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
    J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
    Wölfel T; Klehmann E; Müller C; Schütt KH; Meyer zum Büschenfelde KH; Knuth A
    J Exp Med; 1989 Sep; 170(3):797-810. PubMed ID: 2788708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.
    Knuth A; Danowski B; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3511-5. PubMed ID: 6610177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E
    Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
    van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
    J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma antibodies: specificity and interaction with melanoma and cytotoxic T-cells.
    Dippold WG; Knuth A; Meyer zum Büschenfelde KH
    Behring Inst Mitt; 1984 May; (74):14-8. PubMed ID: 6332614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
    Itoh K; Platsoucas CD; Balch CM
    J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.
    Anichini A; Fossati G; Parmiani G
    Int J Cancer; 1985 May; 35(5):683-9. PubMed ID: 3158614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
    Notter M; Schirrmacher V
    Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 261.